Name your favorite Pfizer Blunder in the last 15 years

Discussion in 'Pfizer' started by Anonymous, Jun 28, 2010 at 11:24 PM.

  1. Anonymous

    Anonymous Guest

    I'll start: pursuing Exubera despite roughly 10 years of FDA concerns about safety. How many billions were pissed away on this product?

    Oh, I left out the decision to have the Arthritis, Pain and Neurology division launch it, instead of the Cardiovascular, Endocrine, and Nephrology division launch it.

    Brilliant.
     

  2. Anonymous

    Anonymous Guest

    Good choice, for all the reasons you list. I was on the APM team that "launched" Exubera and still can't believe how f'd up the whole situation was. Remember Brandt's speech on how the "soft launch" made sense--talk about believing propaganda = reality!! And the "marketing" team's refusal to address the spirometry reimbursement issue--the list goes on and on...

    Here's another nomination: toracetrapib. How many billions did Pfizer spend ramping up production facilities?! And no one, not one researcher, not one clinical trial coordinator EVER saw a CV safety signal or issue?!? Very hard to believe...
     
  3. Anonymous

    Anonymous Guest

    Buying Wyeth for 68bil and telling Wall Street that this will get the stock growing,without laying off many people, and launching CUE telling everyone that this is what is the solution. Now do you understand why severe layoffs are coming this fall?
     
  4. Anonymous

    Anonymous Guest

    Promoting the -og -apper
     
  5. Anonymous

    Anonymous Guest

    The Women in Leadership (WISL) Initiative. Notice how they're all gone now?
     
  6. Anonymous

    Anonymous Guest

    Any part wyeth played in sinking this company makes me very, very happy. Giddy, in fact. May Pfizer get what it deserves. What goes around, comes around.
     
  7. Anonymous

    Anonymous Guest

    2.3 billion.

    game over.
     
  8. Anonymous

    Anonymous Guest

    hiring contract companies
     
  9. Anonymous

    Anonymous Guest

    Hiring Jeff Kindler
     
  10. Anonymous

    Anonymous Guest

    Buying Parke-Davis!
     
  11. Anonymous

    Anonymous Guest

    The lack of samples with Exubera. Doctors told me I was crazy if I expected them to rx and expensive product like Exubera without the patient trying samples first. We saw samples when the product had already failed - too little too late.

    Letting Kindler continue as CEO as long as he has.

    Cutting tenured people and keeping young and inexperienced Ken and Barbies.

    Selling the OTC Division to J & J.

    I have been gone for a year and half. CUE was mentioned earlier as a blunder. Please ellaborate on CUE as I know very little about it.
     
  12. Anonymous

    Anonymous Guest

    Key thought leaders wouldn't even use Exubera with our so called "soft marketing" and marketing thought they could sell this product.
     
  13. Anonymous

    Anonymous Guest

    Buying PD was a giant blunder. PD was going to drop the copromote with Pfizer on Lipitor. If Pfizer had lost Lipitor 10 years ago, Pfizer would have fallen apart a long time ago and saved everyone a lot of misery. Plus Pfizer wouldn't have Lyrica now, to keep it going a few more years.
     
  14. Anonymous

    Anonymous Guest

    Maybe not the biggest - but selling the OTC division. Gee we don't want a successful line of products in a growing business. We'd rather roll the dice on some high risk R & D gamble. Which purchase did Pfizer piss away the proceeds on ? Can't even blame that one on JK, that was a HM blunder.
     
  15. Anonymous

    Anonymous Guest

    Beelzebub is my favorite blunder. How so many at Pfizer could place their faith in something that they knew was wrong I don't know. Yes, the product was a high flier, and Pfizer could have owned the world if this could have been converted into capsule form. Just more money and effort down the rat hole.

    Loki
     
  16. Anonymous

    Anonymous Guest

    Women in Leadership Initiative.
    By far the biggest idiot move of all. Hiring a female VP who was far too stupid to think of all the angles and possiblities, thus the compliance nightmare and subsequent massive lawsuits.
     
  17. Anonymous

    Anonymous Guest

    Parke-Davis would have done just fine without Pfizer. Don't get me started on this. Remember all those Warner-Lambert OTC products that Pfizer also gained and sold. And please don't tell me you would not have wanted Lipitor all to yourself. We were treated like stepchildren when we came aboard and showed we could move market share with products like Zithromax and Zyrtec whose sales were flat. I don't need any miserable Pfizer legacy reps telling me what a mistake this was.
     
  18. Anonymous

    Anonymous Guest

    Not buying the distribution rights to baphometimax, when they could have been gotten so cheaply, was a huge blunder. Sure, there have been problems with other antibiotics in the portfolio, but this would have been the most potent of them all. Just think how easy marketing would have had in giving away free samples. And if only the detailers could sell themselves.

    Loki
     
  19. Anonymous

    Anonymous Guest

    Oh there are so many !!!!

    DCN: Diabetes control network

    Caduet and the 9 box sell sheet

    Tikosyn---it's going to be big !

    Viagra--setting quotas after the product launched---- nice touch !!!

    Exubera----smoke a bong in public--no body will think twice---rrriiiigggghhhhttt

    7 people selling Lipitor!

    Hiring a lawyer to be the CEO.

    RM's promoting off label use of a product.

    2.3 Billion dollar fine.

    Trovan--liver concentrations really don't mean anything.
     
  20. Anonymous

    Anonymous Guest

    Hiring salesmen that whimper much better than they sell.

    Loki